Matteo Brindisi obtained his Master Degree in Pharmacy at the University of Calabria, Italy, in 2017 after a period of Erasmus traineeship at the John Innes Centre in Norwich, UK. Matteo received his PhD in Translational Medicine at the University of Calabria in 2022. During his PhD he worked on in-vitro model of breast cancer with a particular focus on cholesterol and cancer metabolism.
In particular, he focused on ERRα signaling and its contribution during the progression of breast cancer and the cross-talk with the tumor microenvironment. During the first year of his PhD he moved to the University of Salford in Manchester, UK, as visiting PhD student were he investigated the metabolism features of breast cancer cells and in particular of cancer stem cells (CSCs).
As a PostDoc at Vita-Salute San Raffaele University, he continued working on breast cancer focusing mainly on cancer cell motility and pathways related with this feature. Currently, as a PostDoc at the Humanitas Research Hospital, he is conducting a project aiming to clarify the relationship between Med12L, a Tdark gene, and myeloproliferative neoplasms (MPNs).